Navigation Links
Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
Date:5/14/2012

PARIS, May 14, 2012 /PRNewswire/ --


  • Results of head-to-head study comparing two biologic drugs on a background of methotrexate for the treatment of moderate to severe rheumatoid arthritis to be presented

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the company will present 18 abstracts on abatacept at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology in Berlin, June 6-9. Among the data being presented will be results from the AMPLE study, a head-to-head phase 3 clinical trial comparing subcutaneous (SC) ORENCIA® (abatacept) to HUMIRA® (adalimumab), both in combination with methotrexate. The combination of a biologic medication and methotrexate is the most commonly prescribed treatment approach in moderate to severe RA.

AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects With Background Methotrexate) is a randomized, controlled study powered to compare the efficacy of abatacept SC versus adalimumab on a background of methotrexate in adult, biologic naïve patients with moderate to severe RA. AMPLE is an ongoing 2 year study, with primary analyses at 1 year. In addition to assessing the primary endpoint of non-inferiority between abatacept SC and adalimumab as defined by the proportion of subjects achieving the American College of Rheumatology criteria of 20 percent improvement (ACR 20) after 12 months of treatment, the trial also evaluated the following secondary endpoints: frequency of injection site reactions, radiographic non-progression as assessed using the van der Heijde modified total Sharp score (mTSS) method, safety and retention. The study also evaluated addi
'/>"/>

SOURCE Bristol-Myers Squibb
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BT Signs Multi-Year, Managed Services Contract with Bristol-Myers Squibb
2. Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound
3. Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
4. GNS Healthcare Announces Collaboration With Bristol-Myers Squibb
5. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
6. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
7. Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
8. Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
9. Bend Research Announces Extension of Drug-Discovery Enablement and Development Services Agreement With Bristol-Myers Squibb
10. Isis Earns $6 Million Milestone Payment From Bristol-Myers Squibb for BMS-PCSK9Rx
11. Top Bristol-Myers Squibb Executive Joins Patton Boggs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 Pharmacyclics, Inc. (the ... The New England Journal of Medicine ( ... study evaluating the investigational oral Bruton,s tyrosine kinase (BTK) ... (CLL) or small lymphocytic lymphoma (SLL). Ibrutinib was shown ... CLL or SLL, even in patients who were at ...
(Date:6/19/2013)... June 19, 2013 The Physician-Patient Alliance for Health ... The need to urgently address this issue has ... Event Alert #50 , "Medical device alarm safety in hospitals." ... January 2008 and June 2012, there were 98 alarm related ... death (82%) , 13 resulted in permanent loss of ...
(Date:6/19/2013)... YORK , June 19, 2013   Voices ... to finding a cure for brain cancer, today announced ... a grant to support the clinical investigation of Toca ... recurrent high grade glioma brain cancer (Grade 3 or ... developing novel treatments for advanced cancer, with an initial ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
... , NEW ... market research report is available in its catalogue. , ... http://www.reportlinker.com/p0164740/US-Market-for-PACS-and-EMR.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , ... almost $1.3 billion, representing an increase of 6.7% over ...
... ... Reportlinker.com announces that a new market research report ... Nonwoven Disposables - A Worldwide Market Review ... , With increase in range of infectious ...
Cached Medicine Technology:Reportlinker Adds U.S. Market for PACS and EMR 2Reportlinker Adds U.S. Market for PACS and EMR 3Reportlinker Adds U.S. Market for PACS and EMR 4Reportlinker Adds U.S. Market for PACS and EMR 5Reportlinker Adds U.S. Market for PACS and EMR 6Reportlinker Adds U.S. Market for PACS and EMR 7Reportlinker Adds U.S. Market for PACS and EMR 8Reportlinker Adds U.S. Market for PACS and EMR 9Reportlinker Adds U.S. Market for PACS and EMR 10Reportlinker Adds U.S. Market for PACS and EMR 11Reportlinker Adds U.S. Market for PACS and EMR 12Reportlinker Adds U.S. Market for PACS and EMR 13Reportlinker Adds U.S. Market for PACS and EMR 14Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 2Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 3Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 4Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 5Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 6Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 7Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 8Reportlinker Adds Medical Nonwoven Disposables - A Worldwide Market Review 9
(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...
(Date:6/19/2013)... Brain not working? Functional medicine pioneer ... such seemingly minor brain problems as brain fog, memory ... flags. They indicate the brain may be degenerating—or aging—too ... Parkinson’s, stroke, and other neurological diseases. Why Isn’t ... Elephant Press is now available online at Amazon ...
(Date:6/19/2013)... 19, 2013 Today, Zane Benefits, Inc. ... Exchange . Zane Benefits, which provides comprehensive and flexible ... leader in defined contribution and health ... website, as part of the Affordable Care Act (ACA), ... become available through new state health insurance exchanges. , ...
(Date:6/19/2013)... June 19, 2013 According to a June ... Weekend Sunburn,” it is not uncommon for a person to ... months. A person is likely to forget to reapply sunscreen ... is both dry and itchy. When this occurs, it is ... goo.gl/gDyjP). , “Most people do not realize that milk contains ...
(Date:6/19/2013)... ANGELES (June 19, 2013) In what is believed ... the most common form of hereditary dystonia a ... experts in deep brain stimulation report good success rates ... of the Movement Disorders Program at Cedars-Sinai Medical Center,s ... of the Division of Neurosurgery at Beth Israel Deaconess ...
Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Skin Care – How to treat Sunburn 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2
... SURESNES, France and ISMANING, Germany, Oct. 17 ... leader in security solutions,for remote transactions, and ... leading provider of solutions that open the ... develop mobile eHealth,smart card terminals for the ...
... to Receive $100,000 Prize in World,s Largest Spokesmodel Competition,Vote online now for ... ... Right Foundation, NEW ORLEANS, Oct. 16 Planet Beach announced ... on November 14th at the Hard Rock Hotel and Casino in,Biloxi, Mississippi. ...
... incomes are particularly challenged by rising expenses, including housing, healthcare and ... ... Ill. (Vocus) October 16, 2008 -- For the more than 8.5 ... a decision on their application for benefits, the 5.8 percent cost ...
... and Graduate Programs, Now Offered at the College, ... Trustees, in,conjunction with President James J. Gozzo, Ph.D., announced ... to become Albany College,of Pharmacy and Health Sciences. The ... Education, has been chosen to better reflect the broad ...
... Productivity and Savings, DALLAS, Oct. 16 ... further decisive action from Washington leaders,employers and consumers, ... Inc. (http://www.USPreventiveMedicine.com ), the leader in,disease prevention ... says it is influencing the nation,s economic viability ...
... with Explicit Business Acumen and Harder Financial Focus , ... ... -- The Perth Leadership Institute ( alert on the market ... quickly and effectively develop a post-crash leadership strategy. The alert ...
Cached Medicine News:Health News:XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market 2Health News:XIRING and SCM Microsystems Jointly Develop Mobile Terminals for German eHealth Market 3Health News:Ms. Planet Beach International to be Hosted by Ali Landry and Lorenzo Lamas 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 3Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 4Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 5Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 6Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 7Health News:Albany College of Pharmacy and Health Sciences - New Name, Same Commitment to the Advancement of Health Care 2Health News:Prevention is the Key to Solving Health Care Crisis; 2Health News:Prevention is the Key to Solving Health Care Crisis; 3Health News:Perth Leadership Institute Issues Alert on the Post-Crash Environment Facing HR/Leadership Development 2Health News:Perth Leadership Institute Issues Alert on the Post-Crash Environment Facing HR/Leadership Development 3
The Lang Stereotest was created to simplify stereopsis screening in children. It is based on two principles: random dots and cylindrical gratings. The Lang Stereotest I measures disparities: Star 600...
... three test plates(6mm, 3mm, and 1.5mm thick), which ... 600 - 15 seconds. No special glasses are ... if stereopsis is present. Test plates can be ... learning the correct answer. Large stereo acuity range. ...
Comes with seven test plates. Red and green glasses filters are mounted in two frames, one for adults and one for children. Suitable for testing very small children as well as adults....
... designed to assist patients with red-green color deficiencies ... cuts off wavelengths shorter than 582 nm enabling ... their most difficult color distinctions. A color anomalous ... whether a color is in the longer or ...
Medicine Products: